Implementation Evidence for New Vaccine Delivery
We work alongside vaccine developers, health facilities, governments, and global health partners to test how new delivery platforms perform in real-world immunization systems.
By generating the implementation evidence these platforms need, we help turn promising innovations into programs that reach children at scale.
Our Approach
Microneedle Vaccine Patch Delivery
Microarray patches deliver vaccines through the skin without a needle. They are painless, simple to apply, and reduce the cold chain and personnel requirements that limit immunization.
We work alongside patch developers to test how these platforms perform in Nigerian immunization settings, beginning with measles-rubella and extending to other antigens.
Implementation Readiness (MIRF)
Our MAP Implementation Readiness Framework assesses whether a facility is prepared to deliver a new vaccine platform, across acceptability, usability, operational feasibility, workforce and institutional readiness.
Each domain produces a score identifying where a site is ready and where support is needed, so gaps are addressed before rollout.
(opens in new tab)Read the Discussion Brief →(opens in new tab)
(opens in new tab)
Biometric Vaccine Verification
We integrate fingerprint recognition and digital ID verification into immunization workflows, so every dose can be reliably matched to the child who received it.
Where records are paper-based and follow-up is difficult, this confirms administration, prevents missed doses, and tracks complete immunization. A child can also be identified at any site in the programme, not only where they first registered.
Research & Partnerships
We design and run clinical and implementation research in Nigerian immunization settings, covering protocol development, regulatory coordination, site readiness, and participant-centered study conduct. This work is led by LunaVax Institute Nigeria, our Nigerian research entity.
By partnering with health facilities, governments, and global health allies, we co-design and scale vaccine access solutions across the immunization system.
The Future We’re Building
We’re working toward a self-sufficient vaccine ecosystem in Africa, including local production of next-generation vaccine platforms and last-mile delivery through mobile and autonomous systems. Our work today focuses on building the evidence to make that future possible.